Live Science1 小时
Editor's picks: 2024's most exciting technology advancements
AI dominated tech news this year, but has the technology actually been improving? We review the leaps we've seen, as well as ...
Pharmaceutical Technology23 小时
HMBD-001 by Hummingbird Bioscience for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
HMBD-001 is under clinical development by Hummingbird Bioscience and currently in Phase I for Pancreatic Ductal Adenocarcinoma.
Pharmaceutical Technology23 小时
Zanzalintinib fumarate by Exelixis for Hypopharyngeal Cancer: Likelihood of Approval
Zanzalintinib fumarate is under clinical development by Exelixis and currently in Phase III for Hypopharyngeal Cancer.